| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2008-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100795839-B1 |
| titleOfInvention |
Mucosal vaccine adjuvant containing bacterial flagella constituent flagellin as an active ingredient |
| abstract |
The present invention relates to a mucosal vaccine adjuvant containing the flagella constituent flagellin of bacteria derived from Vibrio vulnficus , Salmonella typhimurium and Listeria monocytogenes as an active ingredient. . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11254714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023075421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014084456-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10407471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102483177-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230111815-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180064813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102514849-B1 |
| priorityDate |
2004-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |